Guide library
Plain-language education with dates, authors and original source links where available.
Prime Scientific Peptides Deconstructing Prime Scientific Peptides:Empirical Stability Tracking and Logging The evolution of peptide characterization methods has shifted toward high-resolution mass spectrometr…
Read guide →Classification Of Peptides With Examples Why Classification Of Peptides With Examples Matters in Modern Peptide Science Rational design based on molecular recognition principles enables construction of selecti…
Read guide →Niacinamide Peptide 24 Anti Wrinkle Serum Niacinamide Peptide 24 Anti Wrinkle Serum Explained for Non-Scientists:Clear and Concise The evolution of peptide science has entered a new phase defined by precision-…
Read guide →Biomist Labs Peptides Mapping Biomist Labs Peptides:Compatibility Screening and Ingredient Interaction The evolution of peptide characterization methods has shifted toward high-resolution mass spectrometry and…
Read guide →With quarterly earnings underway, BioPharma Dive is providing a snapshot of some companies’ results and how they’re being received by investors. Today, we’re offering insight into the latest numbers from Neuro…
Read guide →Dive Brief: The Food and Drug Administration has declined to review an application to approve Moderna’s messenger RNA-based influenza vaccine in a surprise decision that represents another regulatory setback f…
Read guide →Dimension, a young venture capital firm at the vanguard of biotechnology’s embrace of artificial intelligence, has closed its biggest fund to date. The firm on Tuesday announced it raised $800 million for “Dim…
Read guide →When drug developers go after the same disease, clinical trial results often have a see-saw effect on the stock market. Investors inevitably view one company’s data as stronger than its rivals, and share price…
Read guide →Beeline Medicines has attracted another $126.3 million in funding, the company said Tuesday , adding to an enormous Series A round originally announced in the spring to fund its work on drugs for immune condit…
Read guide →Arctic Berry Peptide Eminence What I Learned from Formulating Arctic Berry Peptide Eminence Over the Years Successive waves of technological advancement have, over time, transformed peptide synthesis from a sp…
Read guide →Scribe Therapeutics, a biotechnology startup developing genetic medicines for cardiometabolic disorders, has revealed plans to chase an initial public offering. In a filing with the Securities and Exchange Com…
Read guide →Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback . Dive Brief: Royalty management company Zymeworks is buying Theravance Biopharma, announcing Monday a $929 mil…
Read guide →The Food and Drug Administration approved Friday Viridian Therapeutics’ treatment Lumvoa for thyroid eye disease, setting up a showdown between Amgen’s blockbuster medicine Tepezza and the drug analysts believ…
Read guide →Today, a brief rundown of news from Lyell Immunopharma and Biogen as well as updates from the European Life Sciences Coalition and Novocure that you may have missed. Lyell Immunopharma said Thursday it has beg…
Read guide →Atlanta biotechnology company Altesa BioSciences announced Thursday it closed a $75 million Series B round to advance a drug it sees as helpful treating multiple chronic lung conditions. Altesa’s drug vapendav…
Read guide →Korsana Biosciences, a biotechnology company making a treatment for Alzheimer’s disease, officially emerged from stealth Wednesday with $175 million to round out its portfolio of drugs for neurodegenerative co…
Read guide →Dive Brief: Shares for Vir Biotechnology climbed by nearly 30% Tuesday after the company reported positive early data as well as a partnership involving an experimental drug it’s developing for prostate cancer…
Read guide →Dive Brief: Ipsen plans to buy Memo Therapeutics to expand its rare disease pipeline, adding an experimental medicine poised to start a pivotal trial this year. Investors in Switzerland-based Memo will receive…
Read guide →Dive Brief: Drug developers making new medicines to treat autoimmune conditions and cancer made up more than 40% of the venture funding rounds in the first half of 2026, BioPharma Dive data show . Of the more …
Read guide →Celea Therapeutics, a biotechnology startup testing a next-generation treatment for idiopathic pulmonary fibrosis, said in a Thursday announcement it has brought in $180 million to continue its work. Launched …
Read guide →